170 related articles for article (PubMed ID: 20652611)
1. Speech-induced primary lingual dystonia: a rare focal dystonia.
Ozen B; Gunal DI; Turkmen C; Agan K; Elmaci NT
Neurol Sci; 2011 Feb; 32(1):155-7. PubMed ID: 20652611
[TBL] [Abstract][Full Text] [Related]
2. Isolated lingual dystonia induced by speaking: a rare form of focal dystonia.
Degirmenci Y; Ors CH; Yilmaz Y; Karaman HI
Acta Neurol Belg; 2011 Dec; 111(4):360-1. PubMed ID: 22368983
[TBL] [Abstract][Full Text] [Related]
3. Case Report: Isolated Lingual Dystonia.
Yousafzai ZA; Qayyum W; Khan S; Iftikhar M; Amin QK
F1000Res; 2020; 9():314. PubMed ID: 33145008
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis and treatment of abductor hallucis focal dystonia with botulinum toxin injection: a case presentation.
Rosenberg NS; Odderson IR
PM R; 2013 Aug; 5(8):726-8. PubMed ID: 23953019
[No Abstract] [Full Text] [Related]
5. Isolated lingual dystonia : responding to anticholinergic treatment.
Verma A; Yadav R
J Assoc Physicians India; 2011 Aug; 59():526-7. PubMed ID: 21887917
[TBL] [Abstract][Full Text] [Related]
6. The broadening application of chemodenervation in X-linked dystonia-parkinsonism (Part II): an open-label experience with botulinum toxin-A (Dysport®) injections for oromandibular, lingual, and truncal-axial dystonias.
Rosales RL; Ng AR; Santos MM; Fernandez HH
Int J Neurosci; 2011; 121 Suppl 1():44-56. PubMed ID: 21348790
[TBL] [Abstract][Full Text] [Related]
7. Botulinum Neurotoxin Therapy for Lingual Dystonia Using an Individualized Injection Method Based on Clinical Features.
Yoshida K
Toxins (Basel); 2019 Jan; 11(1):. PubMed ID: 30658420
[TBL] [Abstract][Full Text] [Related]
8. [Botulin A toxin: a highly effective drug in the treatment of focal dystonia].
Timerbaeva SL; Ivanova-Smolenskaia IA; Markova ED; Poleshchuk VV; Karapetian MV; Rebrova OIu
Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(5):32-5. PubMed ID: 10849964
[No Abstract] [Full Text] [Related]
9. Botulinum toxin in a task-specific oromandibular dystonia in a bingo caller.
Díaz-Sánchez M; Martínez-Castrillo JC
J Neurol; 2008 Jun; 255(6):942-3. PubMed ID: 18481036
[No Abstract] [Full Text] [Related]
10. [Camptocormia--segmental dystonia. Proposal of a new definition for an old disease].
Reichel G; Kirchhöfer U; Stenner A
Nervenarzt; 2001 Apr; 72(4):281-5. PubMed ID: 11320863
[TBL] [Abstract][Full Text] [Related]
11. Primary lingual dystonia induced by speaking.
Baik JS; Park JH; Kim JY
Mov Disord; 2004 Oct; 19(10):1251-2. PubMed ID: 15390005
[TBL] [Abstract][Full Text] [Related]
12. Adult-onset primary focal foot dystonia.
Singer C; Papapetropoulos S
Parkinsonism Relat Disord; 2006 Jan; 12(1):57-60. PubMed ID: 16154790
[TBL] [Abstract][Full Text] [Related]
13. Isolated speech-induced lingual dystonia successfully treated with botulinum neurotoxin.
Cores-Bartolomé C; Paz-González JM; García-Antelo MJ; Santos-García D
Neurologia (Engl Ed); 2022 May; 37(4):306-308. PubMed ID: 35595406
[No Abstract] [Full Text] [Related]
14. [Treatment of focal dystonia with botulinum toxin A].
Sojer M; Wissel J; Müller J; Poewe W
Wien Klin Wochenschr; 2001; 113 Suppl 4():6-10. PubMed ID: 15506045
[TBL] [Abstract][Full Text] [Related]
15. Familial focal dystonia.
Jiménez-Jiménez F; Martínez-Castrillo JC; Barón-Rubio M; Zurdo JM; de Toledo-Heras M; Vidal L; Hoenicka J
Eur Neurol; 2002; 48(4):232-4. PubMed ID: 12422077
[No Abstract] [Full Text] [Related]
16. Hyoid muscle dystonia: A distinct focal dystonia syndrome.
Norby E; Orbelo D; Strand E; Duffy J; Ekbom D; Bower J; Matsumoto J
Parkinsonism Relat Disord; 2015 Oct; 21(10):1210-3. PubMed ID: 26324211
[TBL] [Abstract][Full Text] [Related]
17. Pilot Single-Blind Trial of AbobotulinumtoxinA in Oromandibular Dystonia.
Scorr LM; Silver MR; Hanfelt J; Sperin E; Freeman A; Jinnah HA; Factor SA
Neurotherapeutics; 2018 Apr; 15(2):452-458. PubMed ID: 29542022
[TBL] [Abstract][Full Text] [Related]
18. Focal lingual dystonia, urinary incontinence, and sensory deficits secondary to low voltage electrocution: case report and literature review.
Baskerville JR; McAninch SA
Emerg Med J; 2002 Jul; 19(4):368-71. PubMed ID: 12101168
[TBL] [Abstract][Full Text] [Related]
19. Effects of Botulinum Toxin Therapy on Health-Related Quality of Life Evaluated by the Oromandibular Dystonia Rating Scale.
Yoshida K
Toxins (Basel); 2022 Sep; 14(10):. PubMed ID: 36287925
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment of open jaw and jaw deviation dystonia with botulinum toxin using a simple intraoral approach.
Moscovich M; Chen ZP; Rodriguez R
J Clin Neurosci; 2015 Mar; 22(3):594-6. PubMed ID: 25541097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
